N/A Completed N=118 Other

Repeat Insult Patch Test APPENDIX I to HRL Standard Protocol #100

Allergic Sensitization

Source: ClinicalTrials.gov NCT03450070 ↗

Enrolled (actual)

118

Serious AEs

0.0%

Results posted

Apr 2019

Primary outcomePrimary: Number of Participants That Did Not Have Test Material Induced Clinically Significant Dermal Irritation — 110 Participants

Summary

Patch Testing for device cream on human subjects

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Participants That Did Not Have Test Material Induced Clinically Significant Dermal Irritation	110	—

Eligibility Criteria

Inclusion Criteria

Male or Female
18+ years
Good health
Signed and datad Informed Consent
Signed and dated HIPAA

Exclusion Criteria

On test at any other research lab or clinic
Known allergy or sensitivity to cosmetics or toiletries
Pre-existing other medical conditions
Treatment with antibiotics, antihistamines, or corticosteroids within 2 weeks of the test
Chronic medication which could affect the outcome of the study
Known pregnant or nursing women
Cancer diagnosis within the past 5 years

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03450070). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.